Press

Recent Press

Icelandic drugmaker Actavis saidon Tuesday it aimed to join the race to develop generic copiesof pricey biotech medicines by buying a majority stake in Polishgroup Bioton's BOTN.WA BioPartners unit.

Read more »

Would you start to sweat if you accidentally deleted a crucial spreadsheet you’d toiled over using Google Docs? Would your spouse wail if someone hacked into your Flickr account and deleted the years of vacation photos you’ve uploaded there?

Read more »

The trade deficit is soaring. Home sales are plunging. Companies uncertain about the future are sitting on growing piles of cash rather than hiring or expanding.  Those are the sorts of recent trends that have been adding to the malaise stemming from still-high unemployment and slumping financial markets.

Read more »

Most of the time, when an analytics score is delivered, users are met with an  apparently arbitrary number, like in Klout, HubSpot Graders, etc. I enjoy the perspective, but don’t always know exactly what all of the factors really mean. Back end “special sauce” algorithms make many of the scores determining factors in how well you’re “using them,” but they don’t usually help users understand exactly what to do if they want to change anything about performance.

Read more »